Unbiased Analysis of Today's Healthcare Issues
Last month, the Government Accountability Office released a report on the cost of rare disease. The report is interesting, and especially interesting is Appendix 1 which has a detailed list of studies of the cost of rare disease for about 50 rare diseases. Below are some highlights: Currently, there are no treatments or cures for…
A very timely paper by my PRECISIONheor colleague Caroline Huber on the economic burden of Ebola in West Africa in 2014: Current estimates of the economic burden of the [2014 West Africa Ebola virus disease (EVD)] outbreak range from $2.8 to $32.6 billion in lost gross domestic product. We estimated the comprehensive economic and social…
The the health and economic of serious mental illness (SMI) is often overlooked by the health policy and some provider communities. One key question is how how can we quantify the economic burden of SMI. Further, how can we reduce this burden. Much of my research has looked at how medications can improve health and…
That is the conclusion from a Bloomberg article highlighting some research done by some of my colleagues at Precision Health Economics in conjunction with the Alzheimer’s Association. An excerpt is below. The Alzheimer’s Association commissioned researchers at Precision Health Economics to study the potential savings of obtaining an earlier diagnosis. It used data from the Health…